Caffeine-Operated Synthetic Modules for Chemogenetic Control of Protein Activities by Life Style.
Wang T, He L, Jing J, Lan TH, Hong T, Wang F, Huang Y, Ma G, Zhou Y
Adv Sci (Weinh). 2020 Dec 13;8(3):2002148. doi: 10.1002/advs.202002148. eCollection 2021 Feb. PubMed Article
Wang T, He L, Jing J, Lan TH, Hong T, Wang F, Huang Y, Ma G, Zhou Y
Adv Sci (Weinh). 2020 Dec 13;8(3):2002148. doi: 10.1002/advs.202002148. eCollection 2021 Feb. PubMed Article
Plasmids from Article
| ID | Plasmid | Purpose |
|---|---|---|
| 169683 | EGFP–acVHH (Y104F)–PB | A COSMO mutant (Y104F) responds to caffeine to induce dimerization of a phospholipid-binding polybasic domain with subsequent plasma membrane translocation. |
| 169684 | EGFP–COSMO–PB | COSMO responds to caffeine to induce dimerization of a phospholipid-binding polybasic domain with subsequent plasma membrane translocation. |
| 169685 | EGFP–acVHH–PB | An anti-caffeine nanobody responds to caffeine to induce dimerization of a phospholipid-binding polybasic domain with subsequent plasma membrane translocation. |
| 171071 | EGFP-acVHH (Y34F)-PB | A COSMO mutant (Y34F) responds to caffeine to induce dimerization of a phospholipid-binding polybasic domain with subsequent plasma membrane translocation. |
| 171072 | EGFP-acVHH (Y34W)-PB | A COSMO mutant (Y34W) responds to caffeine to induce dimerization of a phospholipid-binding polybasic domain with subsequent plasma membrane translocation. |